STOCK TITAN

Zura Bio (NASDAQ: ZURA) discloses resignation of director Someit Sidhu

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Zura Bio Limited reported a board change. On May 20, 2026, director Someit Sidhu informed the company that he will resign from the board of directors, effective May 21, 2026. The company states that his resignation is not due to any disagreement regarding its operations, policies or practices.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Notification date May 20, 2026 Date director informed Zura Bio of resignation
Resignation effective date May 21, 2026 Effective date of Someit Sidhu’s board resignation
Share par value $0.0001 per share Par value of Class A ordinary shares listed on Nasdaq
Company address 1489 W. Warm Springs Rd. #110 Principal executive offices in Henderson, NV 89014
Emerging growth company regulatory
"Emerging growth company x"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Item 5.02 regulatory
"Item 5.02 Departure of Directors or Certain Officers"
Securities Exchange Act of 1934 regulatory
"pursuant to the requirements of the Securities Exchange Act of 1934"
Nasdaq Stock Market market
"ZURA | | The Nasdaq Stock Market"
The Nasdaq Stock Market is a place where many companies' shares are bought and sold, functioning like a marketplace for investing in businesses. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping people grow their wealth or fund business growth. Known for hosting many technology and innovative companies, it is a key indicator of the health of those sectors.
false 0001855644 0001855644 2026-05-20 2026-05-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

Form 8-K

 

 

 

Current Report

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

May 20, 2026

Date of Report (Date of earliest event reported)

 

Zura Bio Limited

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   001-40598   98-1725736
(State or other jurisdiction of
incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

1489 W. Warm Springs Rd. #110

Henderson, NV 89014

 (Address of principal executive offices,
including zip code)

(702) 825-9872

 (Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Class A Ordinary Shares, par value $0.0001 per share   ZURA   The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Director Resignation

 

On May 20, 2026, Someit Sidhu notified Zura Bio Limited (the “Company”) of his decision to resign from the board of directors of the Company effective as of May 21, 2026. Mr. Sidhu’s resignation is not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ZURA BIO LIMITED
   
Date: May 22, 2026 By: /s/ Kim Davis
    Kim Davis
    Chief Operating Officer, Chief Legal Officer and Corporate Secretary

 

 

 

FAQ

What board change did ZURA disclose in this 8-K filing?

Zura Bio Limited disclosed that director Someit Sidhu resigned from its board of directors effective May 21, 2026. The company states the resignation is not due to any disagreement regarding operations, policies, or practices.

When is Someit Sidhu’s resignation from ZURA’s board effective?

His resignation from Zura Bio Limited’s board is effective on May 21, 2026. He notified the company of his decision on May 20, 2026, providing one day’s notice before the effective date.

Did Zura Bio indicate any disagreement behind the director’s resignation?

Zura Bio states that Someit Sidhu’s resignation is not due to any disagreement with the company. This covers matters relating to its operations, corporate policies, or business practices according to the disclosure language.

Which SEC item does Zura Bio use to report the director resignation?

Zura Bio reports the resignation under Item 5.02, which covers departures or appointments of directors and certain officers. This item also includes compensatory arrangements, although none are described in the provided excerpt.

On which exchange are Zura Bio’s Class A ordinary shares listed?

Zura Bio’s Class A ordinary shares are listed on The Nasdaq Stock Market under the trading symbol ZURA. The shares have a par value of $0.0001 per share according to the disclosure.

Filing Exhibits & Attachments

3 documents